EmitBio Inc.: Clinical Trials

5 trials sponsored by EmitBio Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 4, Terminated 1

Follow EmitBio Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient Setting
RDX-19 - Post COVID-19 Condition (PCC)
Not applicableTerminatedEmitBio Inc.412023-10-302024-07-05
Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19
RD-X19, Sham - COVID-19
Not applicableCompletedEmitBio Inc.3302023-04-212024-10-24
Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19
RD-X19, Sham - COVID19
Not applicableCompletedEmitBio Inc.2162021-06-172024-09-19
Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19
RD-X19 - COVID19
Not applicableCompletedEmitBio Inc.312020-11-182022-09-08
Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens
RD19 - Respiratory Tract Infections
Not applicableCompletedEmitBio Inc.252020-08-312024-10-03

Conditions studied

COVID-19 (3)  ·  Respiratory Tract Infections (1)

Countries

United States (5)

Top investigators

Lisa M Cohen, DO (1)